Search results
Find Out Who Owns Jeep in 2024 | The Motley Fool
The Motley Fool· 2 days agoThe automaker's roots date back to World War II, and the company's vehicles have been serving the needs of American drivers (on and off-road) for...
Drugmakers frequently pay physicians to endorse products on social media, study finds
BenefitsPRO· 2 days ago"The conflict of interest may not be apparent to the general social media audience," researchers...
Why Regeneron Stock Finally Joined The 1,000-Club
Investor's Business Daily· 2 days agoEnthusiasm is growing for a looming approval in COPD treatment.
New AI Tool Finds Rare Variants Linked to Heart Di | Newswise
Newswise· 5 days agoUsing an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in 17 genes
Icahn School of Medicine at Mount Sinai Awarded $2 | Newswise
Newswise· 5 days agoNew York, NY [June 10, 2024]—Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a $21 million grant from the National Institute on Aging (NIA) of the National Institutes ...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks· 5 days agoFree Report) announced that the FDA has approved the expanded use of its respiratory syncytial virus (RSV) vaccine, Arexvy for adults aged 50-59 who are at increased risk of RSV disease. Arexvy ...
JD Supra: IRA Litigation Updates: D.N.J. Rejects Challenges from BMS and Janssen; Four Cases Now on...
JD Supra· 6 days agoThe district court rejected those claims, holding (i) “there can be no taking when participating in Medicare is voluntary” (which the court noted was in agreement with what the courts in the ...
FTC Warns Pharma Companies It Means Business with Its Orange Book Listing Policy | JD Supra
JD Supra· 3 days agoPolicy differences are endemic in politics, and the phrase "causing more heat than light" regarding federal drug policy comes readily to mind listening to the rhetoric coming from the Federal ...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 3 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell therapy for B-cell...
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Investor's Business Daily· 2 days agoRivals Are Coming Dupixent is likely to be the first biologic treatment for COPD to hit the market....